2013 doctor in medicina cu teza “Ateroscleroza accelerata in lupusul eritematossistemic” (6508/19.12.2012) Conducator stiintific: Prof. Univ. Dr. Rodica Chirieac
2008 master “Boli cu determinism imun” (G/0059491) Iasi, Facultatea de Medicina Generala
2006 licentiata (Y 0083489) UMF “Gr.T.Popa” Iasi, Facultatea de Medicina Generala
EXPERIENȚĂ DIDACTICĂ:
2021- prezent, șef de lucrări doctor la Facultatea de Medicină și Științe Biologice, Universitatea ”Ștefan cel Mare” din Suceava.
2020 – 2021, șef de lucrări doctor la Departamentul de Sănătate și Dezvoltare Umană, Facultatea de Educație Fizică și Sport, Universitatea „Ștefan cel Mare” din Suceava.
Discipline predate:
Semiologie
Fiziopatologie
MEMBRU ÎN PROIECTE DE CERCETARE:
I. IASP Grant: Musculoskeletal pain academy, 2011, IASP Developing Countries Project: Initiative for improving pain education; jul2011-jul2012; (acord UMF “Gr.T.Popa” Iasi nr.12119/28.06.2011); finantare IASP 7000 USD;
II. EUSTAR Clinical Project CP34: Early Accelerated Atherosclerosis in Systemic Sclerosis (SSAS), grant EUSTAR 2011-2015; UCN-EUSTAR162 (nr.12428/30.06.2011) membri echipa cercetare: Carmen Marina Mihai, UMF Bucuresti (UCN-EUSTAR 100); Valeria Ricerri, Jose Luis Rosales-Alexander (UCN-EUSTAR 094), Patricia Carreira P (UCN-EUSTAR 023), Maria Joao Salvador (UCN-EUSTAR 068), Juan José Alegre Sancho (UCN EUSTAR 123); http://www.eustar.org/ClinicalTrial.html
III. EUSTAR Clinical Project: Very Early Diagnosis of Systemic Sclerosis VEDOSS, 2010-2015 (2020), , PROJECT manager: prof dr. Marco Matucci Cerinic ; aviz nr. ; http://www.eustar.org/Vedoss.html (6681/01/04.2013)
EUSTAR Clinical Project: MEDS; http://www.eustar.org/MedsOnline.html (aviz nr 12528/10.07.2009)
DOMENII DE CERCETARE:
Durerea musculo-scheletala
Ateroscleroza accelerata in LES, PR;
Sclerodermia sistemica
EXPERIENȚĂ PROFESIONALĂ:
medic primar reumatologie, Spital Județean „Sf. Ioan cel Nou” Suceava- concurs iunie 2016
seflucrariSemiologie, Farmacologie Clinica, Imunologie- Facultatea de asistenta medicala generala – Universitatea” Stefan cel Mare”Suceava
cercetatorstiintific ( examen 7-8 sep. 2015)
medic specialist reumatologie (20036/06.01.2014)
ARTICOLE/STUDII IN EXTENSO, PUBLICATE ÎN REVISTE DIN FLUXUL ȘTIINȚIFIC INTERNAȚIONAL PRINCIPAL
Codrina Ancuta, Cristina Pomîrleanu, Claudia Mihailov, Rodica Chirieac, Eugen Ancuta¸, Cristina Iordache, Codruta Bran, Oana Tanculescu, Efficacy of baricitinib on periodontal inflammation in patients with rheumatoid arthritis, Joint Bone Spine 87 (2020) 235-239
Belibou, C., Ancuţa, C., Ancuţa, E., Filoş, C. and Chirieac, R., 2012. Carotid intima-media thickness and plaque as surrogate biomarkers of atherosclerosis among consecutive women with systemic lupus erythematosus. Rom J Morphol Embryol, ”53(1), pp.29-34. IF= 1.5, WOS:000302266600004
Belibou C, Ancuţa C, Miu S., Ancuţa E., Păstrăguş C., Chireac R. Contribuţii la cunoaşterea clinic-biologică a lupusului eritematos sistemic şi relaţia cu indicatorii de activitate şi distrucţie tisulară. Rev. Med. Chir. Soc. Med. Nat., Iaşi – 2012 – vol. 116, nr. 1
Cristina Pomârleanu, Alexandra Jitaru, Raluca Maxim, Codruța Belibou, Codrina Ancuța: A predictive model for Simplified Disease Activity Index (SDAI) remission in rheumatoid arthritis. Revista Română de Reumatologie, București-2015-vol.24, nr.1
Pomîrleanu C, Jitaru A, Maxim R, Belibou C, Ancuta C, Can SDAI remission be predicted in patients with established rheumatoid arthritis treated with anti-TNF agents? Revista Romana de Reumatologie , Bucuresti , 2015, vol. 24, nr. 2
Macovei, Luana; Ancuta, Codrina; Belibou, Codruta, Chirieac, Rodica, Studiul densitatii minerale osoase la paciente cu poliartrita reumatoida. [Bone mineral density in patients with rheumatoid arthritis]. Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi, Volume:115 Issue:3 2010 Pages:723-30, ISSN:0048-7848.
Ancuţa, C., E. Ancuţa, S. Miu, C. Iordache, C. Belibou, and R. Chirieac. Adalimumab therapy in patients with active rheumatoid arthritis. Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi 113, no. 3 2009: 710-715.
Codrina Ancuta, C. Belibou, R, Maxim, A.E.Petrea, C. Pomirleanu, L. Petrariu, G, Strugariu, R. Chirieac, Aspecte de imunogenicitate si eficacitate clinica a inhibitorilor de TNF administrati pe termen lung la pacienti cu patologie reumatismala imun mediata (studiu preliminar). Romanian Journal of Rheumatology 2015, vol XXIV, supplement 2
C. Pomirleanu, A.E.Trifan, G. Strugariu, L. Petrariu, R. Maxim, C. Belibou, Codrina Ancuta, Impactul artropatiei gutoase asupra dizabilitatii si calitatii vietii, Romanian Journal of Rheumatology 2015, vol XXIV, supplement 2
Codrina Ancuta,C. Belibou, R. Maxim, I. Horgot, C. Pomirleanu, L. Petrariu, G, Strugariu, R. Chirieac, Eficacitatea pe termen lung a inhibitorilor de TNF si persistenta pe terapie biologica in artropatia psoriazica. Romanian Journal of Rheumatology 2015, vol XXIV, supplement 2
C. Pomirleanu, R. Maxim, A.E.Trifan, I. Resmerita, G.Strugariu, L. Petrariu, C. Belibou, Codrina Ancuta, Proteina C reactiva, biomarker al severitatii artrozei de genunchi ? Romanian Journal of Rheumatology 2015, vol XXIV, supplement 2
Codrina Ancuta, C. Belibou, R. Maxim, A.E.Petrea, C. Pomirleanu, R. Chirieac, Densitatea minerala osoasa si riscul de fractura in sclerodermia sistemica – experienta unui centru EUSTAR. Romanian Journal of Rheumatology 2015, vol XXIV, supplement 2
Lucrari publicate în rezumat in reviste cotate ISI cu factor de impact
Codrina, A., Cristina Pomirleanu, Georgiana Strugariu, Luiza Petrariu, Raluca Paiu, Eugen Ancuta, Codruta Bran, and Rodica Chirieac. FRI0076 The Risk Of Tuberculosis In Patients With Immune-Mediated Rheumatic Disorders Receiving Biological Therapy: A 15-Year Experience In A Romanian Cohort. 2019: 699-700. Annals Of The Rheumatic Diseases, IF = 14.299, WOS:000472207102119
Codrina, A, Cristina Pomirleanu, Raluca Paiu, Georgiana Strugariu, Luiza Petrariu, Eugen Ancuta, Codruta Bran, Rodica Chirieac, and Claudia Mihailov. 2019FRI0382 Ten-year retention rates of first-line biological agent in axial spondylarthritis in daily practice: a romanian multicentre experience. Annals Of The Rheumatic Diseases, IF = 14.299, WOS:000472207102426
Ancuta, C., Belibou, C., Pomirleanu, C., Mihai, C., Ancuta, I., Carreira, P., Alexander, J., Alegre, J., Riccieri, V., Salvador, M. and Chirieac, R., 2015.Assessment of Subclinical Atherosclerosis in Patients with Systemic Sclerosis: Results from a Multicentric Cohort. Arthritis & Rheumatology, 67, pp.2287-2288 IF= 9.002, WOS:000370860203309
Ancuta, C., C. Pomirleanu, R. Maxim, C. Belibou, E. Ancuta, and R. Chirieac. Bone mineral density and fracture risk in a cohort of systemic lupus erythematosus women in clinical and experimental rheumatology, vol. 34, no. 4, pp. S89-S89. VIA SANTA MARIA 31, 56126 PISA, ITALY: CLINICAL & EXPER RHEUMATOLOGY, 2016. IF=3.238, WOS:000390289700209
Ancuta, C., C. Pomirleanu, R. Maxim, C. Belibou, E. Ancuta, C. Iordache, and R. Chirieac. Determinants of quality of life in systemic lupus erythematosus: a single center experience in Clinical and Experimental Rheumatology, vol. 34, no. 4, pp. S47-S47. VIA SANTA MARIA 31, 56126 PISA, ITALY: CLINICAL & EXPER RHEUMATOLOGY, 2016. IF=3.238, WOS:000390289700102
Ancuta, C., Pomirleanu, C., Belibou, C., Maxim, R., Petrariu, L., Strugariu, G. and Chirieac, R., 2016. THU0129 Clinical outcomes of immunogenicity in rheumatoid arthritis patients under anti-TNF biologics: results from an observational study. ANNALS OF THE RHEUMATIC DISEASES, 2016: 227-227. IF = 14.299, WOS:000401523101111,
Pomirleanu, C., Strugariu, G., Belibou, C., Maxim, R., Petrariu, L. and Ancuta, C., 2016. FRI0483 Is There A Difference in Autoimmune Myopathies with and without Raynaud’s Phenomenon? A Capillaroscopy Study. 613-613. ANNALS OF THE RHEUMATIC DISEASES, 2016. IF = 14.299, WOS:000401523103077.
Ancuta, Codrina, Codruta Belibou, Cristina Pomirleanu, Eugen Ancuta, and Rodica Chirieac. Patient Reported Outcomes after Failure of a TNF alpha Inhibitor in Rheumatoid Arthritis-Switching to Rituximab or Cycling between Anti-TNFs? In Clinical And Experimental Rheumatology, Vol. 32, No. 4, Pp. S38-S38. Via Santa Maria 31, 56126 Pisa, Italy: Clinical & Exper Rheumatology, 2014. IF= 3.238, WOS:000440319800084
Ancuta, C. M., Belibou, C., Ancuta, E., Miu, S., & Chirieac, R. 2013. THU0102 EULAR-DAS28 versus RAPID3 for treatment monitoring in patients with rheumatoid arthritis treated with rituximab. Annals of the Rheumatic Diseases, 71(Suppl 3), 188-189. IF= 14.299. IF = 14.299, WOS:000208898501037.
Ancuta, Codrina, Eugen Ancuta, Cristina Iordache, Codruta Belibou, and Rodica Chirieac. Assessment of health related quality of life with monthly ibandronate in postmenopausal osteoporosis. In Osteoporosis International, Vol. 22, Pp. 308-309. 236 Grays Inn Rd, 6th Floor, London Wc1x 8hl, England: Springer London LTD, 2011. IF= 3.83, WOS:000288662000554
Ancuta, C., L. Macovei, E. Ancuta, C. Belibou, and R. Chirieac. New Horizons For Joint Protection In Rheumatoid Arthritis Under Anti-Tnfs: Focus On Comp Levels. In Clinical And Experimental Rheumatology, vol. 29, no. 1, pp. 198-198. VIA SANTA MARIA 31, 56126 PISA, ITALY: CLINICAL & EXPER RHEUMATOLOGY, 2011. IF=3.238, WOS:000288292000242,
Ancuta, C., C. Pomirleanu, E. Ancuta, C. Iordache, C. Belibou, and R. Chirieac. Lipid profile and pro-thrombotic disorder in systemic sclerosis. In CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, vol. 28, no. 2, pp. S177-S177. VIA SANTA MARIA 31, 56126 PISA, ITALY: CLINICAL & EXPER RHEUMATOLOGY, 2010. IF=3.238, WOS:000279203200374,
Ancuta, C., Ancuta, E., Iordache, C., Belibou, C. and Chirieac, R., 2009, March. Osteoporosis In Ankylosing Spondylitis: Focus On Bone Mineral Density And Bone Metabolism Biomarkers. In Osteoporosis International (Vol. 20, Pp. 82-83). Ashbourne House, The Guildway, Old Portsmouth Road, Artington Gu3 1lp, Guildford, England: Springer London Ltd. IF=3.83, WOS:000273012800192.
Ancuta, C., Ancuta, E., Iordache, C., & Chirieac, R. Iordache C., Taco C., Belibou C.2010.Changes in bone mineral density during anti-TNF alpha therapy in psoriatic arthritis patients. Bone, (47), S191-S192. Calcified Tissue International, IF= 3.265, WOS:000246660000369,
Prezentare orala Codruţa Bran, E Ancuţa, Codrina Mihaela Ancuta: „Terapia biologică şi sarcina în boala reumatismală cu determinism imun” ZileleMedicaleSucevene, mai2019
Prezentare poster C. Bran, C. Belibou, E. Ancuta, C. Ancuta- Long-term survival on etanercept in patients wirh axSpA: preliminary data in a Romanian cohort, CORA, Florence 14-16 mar 2019
Prezentare poster C. Bran, C. Belibou, E. Ancuta, C. Ancuta- A challenging case of rheumatoid arthritis with sacroiliitis, CORA, Florence 14-16 mar 2019
Prezentare poster Assessment of Subclinical Atherosclerosis in Patients with Systemic Sclerosis: Results from the SSAS CohortAmerican Congress of Rheumatology, ACR, San Francisco, USA, nov 2015
Miozita necrozanta cu anticorpi anti-SRP pozitiviprezentare caz clinic in sesiunea plenara “Miozitele”- Chirieac, C. Pomarleanu. L.Petrariu, G.Strugariu, C.Belibou- Congresul National de Reumatologie, Bucuresti 23-26 sep 2015
Leucopenia, Leucocitoza, Trombocitopenia, Trombocitoza, Eritrocitoza în cadrul Manifestări hematologice în bolile reumatismale- Școala de Vară de Reumatologie,Poiana Brașov iul 2015
08 mai 2015 în cadrulcurs III Sclerodermie sistemică– Manifestări cutanate
24 apr 2015 în cadrulcurs II Sclerodermie sistemică: Afectarea musculară
20 mar 2015 în cadrul curs I Sclerodermie sistemică: Criterii de diagnostic
Noi terapii în poliartrita reumatoidă –prezentare orală Zilele Spitalului de Recuperare 23-27 mar, Iași, 2015
Prezentare caz clinic LES- manifestare Woerwag, Sinaia 5-6 mai 2015
Prezentare poster Densitatea minerala osoasa si riscul de fractura in sclerodermia sistemica: experienta unui centru EUSTAR Congresul National de Reumatologie, Bucuresti, sep 2015
Codrina Ancuta, C. Belibou, R. Maxim, A.E.Petrea, C. Pomirleanu, R. Chirieac, Densitatea minerala osoasa si riscul de fractura in sclerodermia sistemica – experienta unui centru EUSTAR- prezentare orala, Congresul National de Reumatologie, sep 2015
Codrina Ancuta,C. Belibou, R. Maxim, I. Horgot, C. Pomirleanu, L. Petrariu, G, Strugariu, R. Chirieac, Eficacitatea pe termen lung a inhibitorilor de TNF si persistenta pe terapie biologica in artropatia psoriazica, Congresul National de Reumatologie, sep 2015
C. Pomirleanu, R. Maxim, A.E.Trifan, I. Resmerita, G.Strugariu, L. Petrariu, C. Belibou, Codrina Ancuta,Proteina C reactiva, biomarker al severitatii artrozei de genunchi ? Congresul National de Reumatologie, sep 2015
Codrina Ancuta,C. Belibou, R, Maxim, A.E.Petrea, C. Pomirleanu, L. Petrariu, G, Strugariu, R. Chirieac, Aspecte de imunogenicitate si eficacitate clinica a inhibitorilor de TNF administrati pe termen lung la pacienti cu patologie reumatismala imun mediata (studiu preliminar), Congresul National de Reumatologie, sep 2015
C. Pomirleanu, A.E.Trifan, G. Strugariu, L. Petrariu, R. Maxim, C. Belibou, Codrina Ancuta, Impactul artropatiei gutoase asupra dizabilitatii si calitatii vietii, Congresul National de Reumatologie, sep 2015